The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
SIP Calculator
Retirement Planning Calculator
Adani Ports and SEZ
Senores Pharmaceuticals Ltd. Share Price
Senores Pharmaceuticals Ltd. (INR)627.15.1 (0.8%) 
Exchange ScripsBSE544319NSESENORESISININE0RB801010
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Senores Pharmaceuticals Ltd. Performance
Market performance
Open price620
High637
Volumes692635
Prev Close627.1
Low616.15
Closing date2025-03-21
Historical performance
1 Year High665.00
3 Year High665.00
5 Year High665.00
1 Year Low435.25
3 Year Low435.25
5 Year Low435.25
Senores Pharmaceuticals Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
2898
Face Value (₹)
10
P/E Ratio
60.82
Dividend Yield
N/A
Senores Pharmaceuticals Ltd. Investment Returns
1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A
Senores Pharmaceuticals Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 613.02 | Bullish |
| 10-DMA | 587.71 | Bullish |
| 20-DMA | 573.69 | Bullish |
| 50-DMA | 543.46 | Bullish |
| 100-DMA | ||
| 200-DMA |
Shareholding Pattern
| Field | Dec-2024 | Sep-2024 |
|---|---|---|
| Promoters | 16 | 16 |
| Foreign Investors | 3 | 3 |
| Domestic Investors | 13 | 13 |
| Public Investors | 49502 | 43691 |
| Government | --- | --- |
Senores Pharmaceuticals Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
| Other Income | 28 | 37 | 5 |
| Operating Profit | 444 | 164 | 24 |
| Interest | 94 | 21 | 6 |
| Depreciation | 100 | 18 | 7 |
| Profit Before Tax | 249 | 124 | 11 |
| Consolidated Net Profit | 315 | 84 | 10 |
| Adjusted EPS | 10 | 9 | 1 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
| Share Capital | 305 | 98 | 87 |
| Total Reserves | 1738 | 357 | 278 |
| Minority Interest | 274 | --- | --- |
| Total Non-Current Liabilities | 1277 | 337 | 122 |
| Total Liabilities | 6069 | 1311 | 587 |
| Capital Work in Progress | 178 | 81 | 3 |
| Total Assets | 6069 | 1311 | 587 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|
| Cash Flow from Operating Activities | -199 | -11 | -104 |
| Cash Flow from Investing Activities | -547 | -483 | -244 |
| Cash Flow from Financing Activitie | 870 | 463 | 365 |
| Net Cash Inflow / Outflow | 125 | -31 | 16 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 60.82.
- 3Y Stock Price CAGR of the stock is None.
- The stock has a beta of 2.9.
- In the last financial year, the company had an EBITDA of ₹444 Million.
- The company generated revenue of ₹2145 Million in the previous financial year.
Senores Pharmaceuticals Ltd.
627.15.1 (0.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1125751.7
No. of Shares: 1795.2
Performance:12.6%
P/L: ₹125751.7
Top Gainers
Similar stocks
Announcing Stock of the Month!
